ELECSYS TOTAL PSA - COFEPRIS Registration 84R2022 SSA
Access comprehensive regulatory information for ELECSYS TOTAL PSA (ELECSYS TOTAL PSA) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 84R2022 SSA and manufactured by PRODUCTOSROCHE, S.A. DE C.V.. The device was registered on February 08, 2022.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
PRUEBAPARALADETECCIÓNCUANTITATIVAINVITRODELANTÍGENO PROSTÁTICO ESPECÍFICO TOTAL (LIBRE YCOMPLEJADO)(TPSA)ENSUEROYPLASMAHUMANOSENLOSANALIZADORESROCHE.JUNTOCONELTACTORECTAL(TR), CONSTITUYE UNA AYUDA EN LA DETECCIÓN DELCÁNCERDEPRÓSTATAENLOSHOMBRESAPARTIRDELOS50AÑOSDEEDAD.ESTAPRUEBASEAPLICAADEMÁSENMEDICIONESSERIADASDELPSATOTALCOMOAYUDAENELMANEJO DE PACIENTES CON CÁNCER. AGENTE DEDIAGNÓSTICOPARAUSOINVITRO.PARAUSOEXCLUSIVOENLABORATORIOS
TEST FOR QUANTITATIVE DETECTIONINVITRODELANTIGEN PROSTATE-SPECIFIC TOTAL (FREE AND COMPLEXED)(TPSA) IN HUMAN PLASMAPLASMA IN ROCHE ANALYZERS. TOGETHER WITH THE ECTAL ACTOR(RT), IT IS AN AID IN THE DETECTION OF PROSTATE CANCER IN MEN OVER 50 YEARS OF AGE. THIS TEST IS ALSO APPLIED IN SERIAL MEASUREMENTS OF THE TOTAL PSA AS AN AID IN THE MANAGEMENT OF CANCER PATIENTS. DIAGNOSTIC AGENTFORUSEINVITRO. FOR exclusive use in laboratories